jRCT2080221154未知2 期
A 4-month Treatment, Randomized, Double-blind, Placebo-Controlled, Multi-centre, Parallel-Group Phase 2 Study to Evaluate Efficacy, Safety and Tolerability of Different Dosing Regimens of AZD1656 as Monotherapy in Japanese Type 2 Diabetes Mellitus Patients
适应症
试验速览
- 阶段
- 2 期
- 发起方
- AstraZeneca
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Randomized, Double-blind, Placebo-Controlled, Multi-centre, Parallel-Group
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •women of non-childbearing potential.
- •Provision of informed consent prior to any study specific procedures
- •Nailve T2DM patients with HbA1c 7.5% or more but 10% or less, or T2DM Patients treated with one or two oral anti-hyperglycaemic agent(s) with HbA1c 7.5% or more but 9.5% or less at enrolment visit (Visit1)
排除标准
- •Clinically relevant medical history or concurrent disease such as cardiovascular disease, renal disease, hepatic disease and haematological disease.
- •The investigator(s) judged that the Subject should not participate in the study according to screening test or medical history.
- •Participation in another clinical trial and/or intake of another investigational drug within the last 30 days prior to enrolment visit
研究者
相似试验
未知
2 期
A 4-month Treatment, Randomized, Double-blind, Placebo-Controlled, Multi-centre, Parallel-Group Phase 2 Study to Evaluate Efficacy, Safety and Tolerability of Different Dosing Regimens of AZD1656 as Monotherapy in Japanese Type 2 Diabetes Mellitus PatientsType 2 Diabetes MellitusJPRN-jRCT2080221154AstraZeneca
进行中（未招募）
1 期
A Controlled Clinical Study of Dupilumab in Patients with Nasal PolypsEUCTR2015-003101-42-HUSANOFI-AVENTIS RECHERCHE ET DEVELOPPEMENT240
进行中（未招募）
1 期
Controlled Clinical Study of Dupilumab in Patients with Nasal Polypsnasal polypsMedDRA version: 19.0 Level: PT Classification code 10028756 Term: Nasal polyps System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2015-003101-42-GBSANOFI-AVENTIS RECHERCHE ET DEVELOPPEMENT276
进行中（未招募）
1 期
Controlled Clinical Study of Dupilumab in Patients with Nasal Polypsnasal polypsMedDRA version: 19.0 Level: PT Classification code 10028756 Term: Nasal polyps System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2015-003101-42-FRSANOFI-AVENTIS RECHERCHE ET DEVELOPPEMENT276
进行中（未招募）
1 期
Controlled Clinical Study of Dupilumab in Patients with Nasal Polypsnasal polypsMedDRA version: 19.0Level: PTClassification code 10028756Term: Nasal polypsSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2015-003101-42-NLSANOFI-AVENTIS RECHERCHE ET DEVELOPPEMENT240